ASCO 2014: A phase 1 trial of MK-3475 combined with Len and Lo-dose Dex in patients with RRMM

David Siegel, MD John Theurer Cancer Center Hackensack, New Jersey, USA A phase 1 (Ph1) trial of MK-3475 combined with lenalidomide (Len) and low-dose dexamethasone (Dex) in patients (pts) with r... Author: InternationalMyelomaFoundation Added: 09/11/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts